Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV.  Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.  World J Gastroenterol 2014; 20:9185-90

The multi-center Pediatric Inflammatory Bowel Disease Network (PIBDNet) cohort study prospectively collected data on thiopurine naïve patients initiating mercaptopurine (6MP) or azathioprine. Patients with a diagnosis of Crohn’s disease (CD) were included in our study upon entering remission as determined by physician global assessment (PGA) within 365 d of initiation of thiopurines.

Read more

Built by Veracity Media on NationBuilder